Market Cap ₹2876 Cr.
Stock P/E 64.5
P/B 1.8
Current Price ₹220
Book Value ₹ 120.2
Face Value 2
52W High ₹304.7
Dividend Yield 0.32%
52W Low ₹ 190.9
Sagar Cements Ltd is engaged within the manufacture of cement. The Company is engaged inside the enterprise of cement and cement-associated products. The Company manufactures various styles of cement, including ordinary Portland cement (OPC) of 53 grade, 43 grade, Portland Pozzalona Cement (PPC) and Sulfate Resistant Cement (SRC) to match numerous want of customers. The cement produced by means of the Company is sold below the brand name, SAGAR. Its products are used for applications, which includes reinforced cement concrete (RCC) works; precast concrete objects, consisting of paving blocks and tiles constructing blocks; pre-stressed concrete additives; runways, concrete roads and bridges; popular civil engineering construction work; asbestos products, together with sheets and pipes, and non-structural works, which include plastering and floors. Its products also are used for mass concreting and plain cement concreting, and for plastering and single storied individual homes. Its plants are situated in Telangana, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 369 | 334 | 502 | 558 | 475 | 576 | 622 | 540 | 587 | 669 |
Other Income | 3 | 2 | 4 | 12 | 15 | 14 | 181 | 4 | 3 | 4 |
Total Income | 372 | 336 | 506 | 570 | 489 | 590 | 803 | 544 | 590 | 673 |
Total Expenditure | 308 | 287 | 441 | 497 | 469 | 528 | 583 | 509 | 527 | 582 |
Operating Profit | 63 | 49 | 65 | 73 | 21 | 62 | 220 | 34 | 63 | 91 |
Interest | 11 | 18 | 47 | 48 | 50 | 51 | 52 | 44 | 47 | 49 |
Depreciation | 20 | 22 | 32 | 37 | 38 | 40 | 42 | 50 | 51 | 56 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 |
Profit Before Tax | 32 | 8 | -13 | -11 | -68 | -29 | 126 | -59 | -20 | -14 |
Provision for Tax | 12 | -1 | 6 | 2 | -24 | -6 | 28 | -17 | -10 | -4 |
Profit After Tax | 20 | 10 | -19 | -13 | -44 | -24 | 98 | -42 | -11 | -10 |
Adjustments | 0 | 1 | 8 | 6 | 7 | 5 | 3 | 2 | 2 | 2 |
Profit After Adjustments | 20 | 10 | -12 | -7 | -37 | -19 | 101 | -40 | -8 | -8 |
Adjusted Earnings Per Share | 1.7 | 0.9 | -1 | -0.6 | -2.8 | -1.4 | 7.7 | -3 | -0.6 | -0.6 |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|
Net Sales | 753 | 814 | 1038 | 1218 | 1175 | 1371 | 1597 | 2230 | 2418 |
Other Income | 5 | 5 | 10 | 5 | 5 | 12 | 13 | 223 | 192 |
Total Income | 759 | 819 | 1048 | 1223 | 1180 | 1383 | 1610 | 2452 | 2610 |
Total Expenditure | 631 | 705 | 890 | 1071 | 991 | 975 | 1321 | 2076 | 2201 |
Operating Profit | 127 | 114 | 159 | 152 | 190 | 408 | 289 | 376 | 408 |
Interest | 42 | 62 | 59 | 63 | 61 | 47 | 92 | 202 | 192 |
Depreciation | 35 | 48 | 54 | 66 | 79 | 81 | 93 | 156 | 199 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 |
Profit Before Tax | 51 | 4 | 46 | 23 | 50 | 281 | 104 | 18 | 33 |
Provision for Tax | 6 | 8 | 19 | 10 | 23 | 95 | 45 | 10 | -3 |
Profit After Tax | 44 | -4 | 26 | 14 | 27 | 186 | 59 | 9 | 35 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 21 | 9 |
Profit After Adjustments | 44 | -4 | 26 | 14 | 27 | 187 | 69 | 29 | 45 |
Adjusted Earnings Per Share | 5.1 | -0.4 | 2.6 | 1.3 | 2.4 | 15.9 | 5.9 | 2.2 | 3.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 40% | 24% | 17% | 0% |
Operating Profit CAGR | 30% | 26% | 19% | 0% |
PAT CAGR | -85% | -31% | -19% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 9% | 11% | 13% | 19% |
ROE Average | 1% | 8% | 6% | 5% |
ROCE Average | 8% | 12% | 10% | 10% |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 549 | 763 | 779 | 844 | 967 | 1191 | 1255 | 1637 |
Minority's Interest | 0 | 0 | 0 | 0 | 54 | 54 | 54 | 51 |
Borrowings | 295 | 350 | 330 | 306 | 287 | 638 | 1129 | 1152 |
Other Non-Current Liabilities | 74 | 56 | 65 | 72 | 107 | 192 | 212 | 163 |
Total Current Liabilities | 328 | 340 | 365 | 506 | 502 | 554 | 775 | 782 |
Total Liabilities | 1247 | 1509 | 1539 | 1728 | 1918 | 2628 | 3425 | 3786 |
Fixed Assets | 957 | 1001 | 1053 | 1244 | 1384 | 1301 | 2048 | 2793 |
Other Non-Current Assets | 73 | 100 | 195 | 145 | 216 | 695 | 634 | 227 |
Total Current Assets | 217 | 408 | 292 | 339 | 317 | 632 | 742 | 765 |
Total Assets | 1247 | 1509 | 1539 | 1728 | 1918 | 2628 | 3425 | 3786 |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 217 | 3 | 162 | 41 | 18 | 3 | 225 | 143 |
Cash Flow from Operating Activities | 129 | 101 | 150 | 133 | 202 | 377 | 87 | 175 |
Cash Flow from Investing Activities | -111 | -151 | -194 | -187 | -227 | -476 | -784 | 170 |
Cash Flow from Financing Activities | -235 | 208 | -77 | 31 | 10 | 322 | 615 | -367 |
Net Cash Inflow / Outflow | -217 | 159 | -121 | -23 | -15 | 222 | -82 | -21 |
Closing Cash & Cash Equivalent | 3 | 162 | 41 | 18 | 3 | 225 | 143 | 175 |
# | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 5.09 | -0.38 | 2.57 | 1.33 | 2.4 | 15.88 | 5.89 | 2.22 |
CEPS(Rs) | 9.08 | 4.28 | 7.83 | 7.77 | 9.46 | 22.74 | 12.92 | 12.57 |
DPS(Rs) | 1 | 0.3 | 0.8 | 0.5 | 0.5 | 1.3 | 0.7 | 0.7 |
Book NAV/Share(Rs) | 63.15 | 74.8 | 76.39 | 77.18 | 84.77 | 101.35 | 106.85 | 125.29 |
Core EBITDA Margin(%) | 14.15 | 11.58 | 13.75 | 12.06 | 15.7 | 24.79 | 13.96 | 6.03 |
EBIT Margin(%) | 10.72 | 7.04 | 9.74 | 7.11 | 9.42 | 20.45 | 9.94 | 8.66 |
Pre Tax Margin(%) | 5.87 | 0.45 | 4.24 | 1.91 | 4.23 | 17.54 | 5.26 | 0.73 |
PAT Margin (%) | 5.13 | -0.42 | 2.44 | 1.12 | 2.26 | 11.63 | 2.99 | 0.33 |
Cash Profit Margin (%) | 9.16 | 4.64 | 7.41 | 6.51 | 8.97 | 16.7 | 7.69 | 6.47 |
ROA(%) | 4.89 | -0.28 | 1.72 | 0.83 | 1.46 | 8.19 | 1.95 | 0.24 |
ROE(%) | 11.62 | -0.6 | 3.41 | 1.74 | 3.06 | 17.43 | 4.84 | 0.59 |
ROCE(%) | 12.98 | 5.94 | 8.37 | 6.63 | 7.88 | 18.96 | 8.26 | 7.5 |
Receivable days | 25.98 | 31.35 | 29.37 | 31.21 | 39.2 | 27.09 | 20.41 | 18.21 |
Inventory Days | 29.59 | 38.93 | 34.76 | 35.96 | 40.5 | 27.39 | 30.74 | 34.44 |
Payable days | 250.06 | 490.48 | 359.33 | 260.33 | 342.74 | 344.07 | 364.47 | 229.02 |
PER(x) | 15.19 | 0 | 71.82 | 98.15 | 25.5 | 9 | 41.95 | 85.15 |
Price/Book(x) | 1.22 | 2.13 | 2.42 | 1.69 | 0.72 | 1.41 | 2.31 | 1.51 |
Dividend Yield(%) | 1.29 | 0.19 | 0.43 | 0.38 | 0.82 | 0.91 | 0.28 | 0.37 |
EV/Net Sales(x) | 1.46 | 2.38 | 2.22 | 1.49 | 0.98 | 1.63 | 2.66 | 1.68 |
EV/Core EBITDA(x) | 8.63 | 17.02 | 14.54 | 11.91 | 6.1 | 5.46 | 14.67 | 9.94 |
Net Sales Growth(%) | 56.69 | 8.02 | 27.55 | 17.29 | -3.48 | 16.69 | 16.45 | 39.62 |
EBIT Growth(%) | 48.8 | -28.31 | 58.31 | -17.5 | 27.8 | 195.67 | -39.95 | 12.03 |
PAT Growth(%) | 118.63 | -108.85 | 769.9 | -48.25 | 95.22 | 601.55 | -68.22 | -85.63 |
EPS Growth(%) | 97.1 | -107.55 | 769.92 | -48.25 | 79.95 | 562.13 | -62.93 | -62.25 |
Debt/Equity(x) | 0.79 | 0.64 | 0.61 | 0.65 | 0.52 | 0.68 | 1.2 | 0.9 |
Current Ratio(x) | 0.66 | 1.2 | 0.8 | 0.67 | 0.63 | 1.14 | 0.96 | 0.98 |
Quick Ratio(x) | 0.38 | 0.87 | 0.54 | 0.38 | 0.4 | 0.92 | 0.69 | 0.63 |
Interest Cover(x) | 2.21 | 1.07 | 1.77 | 1.37 | 1.81 | 7.03 | 2.12 | 1.09 |
Total Debt/Mcap(x) | 0.64 | 0.3 | 0.25 | 0.38 | 0.72 | 0.48 | 0.52 | 0.6 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 50.28 | 50.28 | 45.2 | 45.2 | 45.2 | 45.2 | 45.2 | 48.31 | 48.31 | 48.31 |
FII | 5.8 | 5.24 | 4.47 | 4.33 | 3.97 | 3.92 | 2.99 | 2.56 | 2.84 | 2.71 |
DII | 8.96 | 8.87 | 18.21 | 18.16 | 19.08 | 19.1 | 19.59 | 18.76 | 17.05 | 17.26 |
Public | 34.96 | 35.61 | 32.12 | 32.31 | 31.75 | 31.78 | 32.22 | 30.36 | 31.8 | 31.72 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 5.91 | 5.91 | 5.91 | 5.91 | 5.91 | 5.91 | 5.91 | 6.31 | 6.31 | 6.31 |
FII | 0.68 | 0.62 | 0.58 | 0.57 | 0.52 | 0.51 | 0.39 | 0.34 | 0.37 | 0.35 |
DII | 1.05 | 1.04 | 2.38 | 2.37 | 2.49 | 2.5 | 2.56 | 2.45 | 2.23 | 2.26 |
Public | 4.11 | 4.18 | 4.2 | 4.22 | 4.15 | 4.15 | 4.21 | 3.97 | 4.16 | 4.15 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11.75 | 11.75 | 13.07 | 13.07 | 13.07 | 13.07 | 13.07 | 13.07 | 13.07 | 13.07 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About